PRIMARY STUDY

Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer

Key Findings:  This study on the effects of other compounds from the Cannabis Sativa plant, such as cannaflavin A, causes human bladder cancer cells to die. Further in vivo studies are warranted to better evaluate this activity and understand the mechanism of action as a possible therapeutic adjunct to treat cancer.

Type of Study:  Laboratory Study

Study Result:  Positive

Study Location(s):  Canada

Year of Pub:  2022


Cannabinoids Studied:  Cannabichromene (CBC), Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified), Other Related Compounds

Phytocannabinoid Source:  Unspecified

Route of Administration:  In vitro



Link to study